Tubal Ligation and Fatal Ovarian Cancer in a Large prospective Cohort Study

Several studies suggest that tubal sterilization may decrease the risk of ovarian cancer. Data from the Cancer Prevention Study II were analyzed to examine the relation between tubal ligation and ovarian cancer mortality in a large prospective study. A total of 396,114 women who had not had hysterec...

Full description

Saved in:
Bibliographic Details
Published in:American journal of epidemiology Vol. 145; no. 4; pp. 349 - 357
Main Authors: Miracle-McMahill, Heidi L., Calle, Eugenia E., Kosinski, Andrzej S., Rodriguez, Carmen, Wingo, Phyllis A., Thun, Michael J., Heath, Clark W.
Format: Journal Article
Language:English
Published: Cary, NC Oxford University Press 15-02-1997
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Several studies suggest that tubal sterilization may decrease the risk of ovarian cancer. Data from the Cancer Prevention Study II were analyzed to examine the relation between tubal ligation and ovarian cancer mortality in a large prospective study. A total of 396,114 women who had not had hysterectomies and who had no prior history of cancer (except nonmelanoma skin cancer) were followed prospectively for approximately 9 years from 1982 to 1991. During this time, 799 ovarian cancer deaths were observed. Tubal ligation was significantly associated with a decreased risk of ovarian cancer mortality in an age- and race-adjusted Cox proportional hazards model (hazard ratio (HR) = 0.64, 95% confidence interval (Cl) 0.42–0.96), and the results were essentially unchanged when controlling for potential ovarian cancer risk factors (HR = 0.68, 95% Cl 0.45–1.03). The protective effect appeared to be greater in the first 20 years after the procedure (HR = 0.49, 95% Cl 0.24–0.99) than later (HR = 0.80, 95% Cl 0.48–1.34). No interactions between ever having had a tubal ligation and other covariates were observed. These data suggest that tubal ligation reduces the risk of fatal ovarian cancer. Am J Epidemiol 1997; 145: 349–57.
Bibliography:Reprint requests to Dr. Eugenia Calle, Department of Epidemiology and Surveillance Research, American Cancer Society, National Home Office, 1599 Clifton Road, NE, Atlanta, GA 30329-4251.
ArticleID:145.4.349
istex:816D1ABA8512E9B3EC6CF18E42EA274213B60BE7
ark:/67375/HXZ-1PVR3196-H
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9262
1476-6256
DOI:10.1093/oxfordjournals.aje.a009112